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1. Introduction 
Genetic variants of human serum albumin were 
first described in [1 ] as bisalbuminemia, .e., the 
presence of two serum albumin components on elec- 
trophoresis of the human serum at alkaline pH; one 
of the two components has the same mobility as 
normal serum albumin, the other, corresponding to
the variant, has a mobility faster or slower than the 
normal component. Although a very large number of 
variants have already been described, their classifica- 
tion has been mainly established from criteria of elec- 
trophoretic mobility in different systems [2-5] and 
little information has been obtained about their struc- 
tural abnormality. At present, the structures of only 
two variants have been identified: the first is the one 
of albumin B (albumin Oliphant [6]) in which glutamic 
acid in position 570 (numbering of [7]) is replaced by 
a lysine residue; the second is proalbumin Christchurch 
[8,9], which is a circulating proalbumin variant con- 
taining an abnormal propeptide sequence: Arg-Gty -  
Val-Phe-Arg-Gln,  instead of: Arg -G ly -Va l -Phe-  
Arg-Arg. This abnormal sequence is not cleaved off 
in the hepatocyte as is the normal propeptide. We 
report here the structure of a new variant of serum 
albumin characterized by an abnormal propeptide: 
Arg-Gly-Val -Phe-His-Arg,  that appears not cleaved 
in vivo, but is easily cleaved in vitro by incubation 
with trypsin. 
2. Materials and methods 
Electrophoresis of the serum samples were per- 
formed on Cellogel (Sebia, Issy les Moulineaux) strips 
(5.7 × 14 cm) in 0.01 M veronat 0.05 M Na-veronal- 
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0.06 M Tris buffer (pH 8.6) and in 0.031 M Na-acetate, 
0.004 M EDTA (pH 5.0). 
Isolation of the variant and normal serum albumins 
was performed by preparative electrophoresis oncel- 
logel RS strips (5 × 24 cm) as follows: 1 ml serum 
was mixed with 0.05 ml solution of 0.5% bromophenol 
blue in electrophoresis buffer, and 0.2 ml were applied 
to the cellogeI strip equilibrated inveronal--Tris buffer 
(pH 8.6). After electrophoresis (5 h at 300 V) the 
bands of normal and variant serum albumins, already 
stained with bromophenol b ue, were cut off and 
eluted with distilled water. The eluates from 8--10 
different electrophoresis runs were pooled, desalted 
on Sephadex G-25-fine equilibrated in 0.01 M ammo- 
nium carbonate buffer (pH 8.4) and freeze-dried. Con- 
trols of purity were performed by electrophoresis on
cellogel at pH 8.6 and by SDS--polyacrylamide g t 
electrophoresis according to [ 10]. 
Treatment of the serum with trypsin was performed 
by adding 0.05 ml ofa 0.1% solution of TPCK-trypsin 
(Worthington Biochemicals) in 0.1 M ammonium car- 
bonate buffer (pH 8.0) to 0.1 ml serum. After incuba- 
tion for 2 h at 37°C, the serum was directly examined 
by electrophoresis onCellogel at pH 8.6. Incubation 
of the isolated variant with trypsin was actfieved as 
for serum using a 20 mg/ml solution of variant in 0.1 M 
ammonium carbonate buffer and a ratio of trypsin to 
protein of 0.2% (w/w). 
N-Terminal amino acid determinations were per- 
formed on the normal and variant albumins by dansyla- 
tion in SDS according to [ 11 ]. Dansyl amino acids 
were identified by bidimensional chromatography on 
silica-gel thin layers according to [ 12]. 
N-Terminal amino acid sequence of the isolated 
variant (7 rag) was determined by automatic Edman 
degradation i a Beckman 890C Protein Sequenator 
using 1 M quadrol buffer program. Phenylthiohydan- 
toin derivatives were identified by high-pressure liquid 
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chromatography on C 18 micro-Bondapack (Waters 
Associates) [13] and by gas-chromatography [14]. 
3. Results and discussion 
Bis-albuminemia was discovered in a subject origin- 
ating from the centre of France and family studies 
showed that the abnormality was inherited (Salmon, 
personal communication). No clinical manifestation 
was found associated with the presence of bis-albu- 
minemia. Electrophoresis at pH 8.6 showed that the 
variant had a slower mobil ity than normal albumin 
(f ig.lA), and that almost equal amounts of normal 
and variant albumins were present. Electrophoresis at
pH 5.0 (fig.lB) showed that the abnormal albumin 
migrated slower then another variant already studied 
in our laboratory and found identical to proalbumin 
Christchurch (Y. A. et al. unpublished). 
Incubation of  the serum with trypsin led to a com- 
plete disappearance of the variant on electrophoresis 
at pH 8.6 (fig.2A). The isolated variant was found 
>95% pure by cellulose acetate lectrophoresis (see 
fig.2B); SDS-polyacrylamide g l electrophoresis 
showed that it had the same apparent relative molecular 
mass (Mr) as normal serum albumin (not shown). 
Tryptic digestion of the isolated variant induced a 
complete change in its electrophoretic mobil ity that 
became identical to normal serum albumin (fig.2B). 
After this cleavage no significant change o fM r was 
observed, thus suggesting that trypsin had split a small 
peptide sequence at the N- or C-terminal ends of the 
molecule. N-Terminal amino acid analyses identified 
in the variant an arginine residue instead of aspartic 
acid found in normal albumin. N-Terminal amino acid 
sequence of the variant (fig.3) indicated the presence 
of  an abnormal sequence that can be interpreted as 
the one of an abnormal proalbumin with an arginine 
in position-2 replaced by an histidine residue. Such an 
amino acid substitution can be explained by a single 
nucleotide replacement in the codons for arglnine 
(replacement of CGU or CGC by CAU or CAC). The 
presence of an histidine residue xplains the difference 
of mobil ity at pH 5.0 between proalbumin Lille and 
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Fig.1. (A) Electrophoresis of the serum on cellogel in veronal- 
Tris buffer (pH 8.6): (1) serum with proalbumin Christchurch; 
(2) serum with proalbumin Lille; (3) normal human serum. 
(B) Electrophoresis of the serum in acetate EDTA buffer 
(pH 5.0): (1)normal human serum; (2) serum with proalbumin 
Christchurch; (3) serum with proalbumin Lille. 
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Fig.2. (A)Electrophoresis of the serum with proalbumin Lille 
after incubation with trypsin (electrophoresis on Cellogel at 
pH 8.6): (1) untreated serum; (2) serum incubated 2 h at 37 ° C 
with trypsin. 
(B) Electrophoresis of the isolated variant after incubation 
with trypsin (electrophoresis on ceUogel at pH 8.6): (1) iso- 
lated variant; (2) isolated variant incubated 2 h at 37°C with 
trypsin (enzyme/protein ratio 0.2%); (3) normal serum 
albumin. 
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1 2 3 4 
Asp - A la  - H is  - Lys  - 
-6  -5  -4  -3  -2  - I  
b - Arg  - G ly  - Va l  - Phe  - Arg  - Arg  - Asp  - A la  - H is  - Lys  - 
c - Arg  - G ly  - Va l  - Phe  - H is  - Arg  - Asp  - A la  - H is  - Lys  - 
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d - Arg  - G ly  - Va l  - Phe  - Arg  - G in  - Asp  - A la  - H is  - Lys  
Fig.3. Amino-terminal sequences of: (a) human serum albumin; 
(b) human proalbumin as presumed in [8]; (c) proalbumin 
Lille; (d) proalbumin Christchurch. 
proalbumin Christchurch where arginine in position-1 
is replaced by a glutamine. In the hepatocyte cleavage 
of the propeptide from normal proalbumin may be 
effected in the Golgi vesicles by a specific protease, 
possibly cathepsin B, that recognizes the Arg-Arg 
sequence [15]. In [8,9] it was therefore suggested 
that in proalbumin Christchurch the replacement of 
the second arginine by a glutamine led to an impossi- 
bil ity of cleavage by the cathepsin. Our results con- 
firm this hypothesis as in proalbumin Lille the sub- 
stitution of the first arginine by an histidine in the 
Arg-Arg  sequence leaves the propeptide sequence un- 
cleaved in vivo. However, our experiments show that 
this propeptide sequence is easily cleaved by trypsin, 
as observed for proalbumin Christchurch [9]. The 
presence of equal amounts of  variant and normal serum 
albumins argues also against some regulatory effects 
of  the propeptide on biosynthesis of human serum 
albumin [16]. 
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